Ignite Creation Date:
2025-12-17 @ 4:27 PM
Ignite Modification Date:
2025-12-24 @ 1:34 AM
Study NCT ID:
NCT00760058
Status:
WITHDRAWN
Last Update Posted:
2015-05-12
First Post:
2008-09-24
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOL
Sponsor:
Alcon Research
Organization:
Study Overview
Official Title:
Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOL
Status:
WITHDRAWN
Status Verified Date:
2010-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Enrollment not initiated for study.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the study is to compare the visual outcomes of three aspheric monofocal intraocular lenses after cataract surgery - ACRYSOF® IQ, Tecnis® and Akreos® MI60.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: